Accounting Specialist, New Ventures
Adeola has over 7 years of experience in full-cycle accounting with progressively increasing responsibilities in Financial reporting, Accounts payables and receivables, Financial Analysis, Reconciliations, Budgeting, Financial Controls and Process Improvements.
In his role as Accounting Specialist, New Ventures at MaRS Innovation, Adeola conducts the day-to-day accounting and finance activities for several new ventures within MI’s portfolio, including Encycle Therapeutics, QD Solar, Vasomune Therapeutics, Bright Angel Therapeutics and Fibrocor Therapeutics. He manages their financial reporting and compliance with GAAP (Generally Accepted Accounting Principles).
Prior to joining MaRS Innovation, Adeola was Senior Accounting/Financial Analyst at ProMach Performance Services where he was in charge of month end close process, financial reporting, cash flow forecasting, process improvement and financial controls . He was also actively involved in budgeting and variance analysis and he prepared other financial analysis reports that enabled management decision-making.
Adeola earned his MBA from Morgan State University, Maryland, USA and holds the designation of Chartered Professional Accountant (CPA, CGA Canada). He is also a Fellow (FCCA) of the Association of Chartered Certified Accountant (ACCA Global).